In vitro analysis of new putative biomarkers for OCT2/MATE-mediated renal drug-drug interactions

被引：0
|
作者：
Picurova, J. [1 ]
Mueller, F. [1 ,2 ]
Koenig, J. [1 ]
Stopfer, P. [1 ]
Fromm, M. F. [1 ]
Gessner, A. [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Numberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2024年 / 397卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P075
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [21] Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug-Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective
    Choi, Hee Jae
    Madari, Shilpa
    Huang, Fenglei
    CLINICAL PHARMACOKINETICS, 2024, 63 (06) : 735 - 749
  • [22] Identification of Putative Novel Biomarkers of Organic Anion Transporter 1 and 3 for the Prediction of Transporter-Mediated Drug-Drug Interactions
    Thakur, Aarzoo
    Singh, Dilip K.
    Paine, Mary
    Prasad, Bhagwat
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [23] Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
    Kido, Yasuto
    Matsson, Paer
    Giacomini, Kathleen M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4548 - 4558
  • [24] In Vitro Evaluation of Drug-Drug Interactions of Patiromer With Common Renal and Cardiovascular Drugs
    Schmitt, Jorg S.
    Steck, Anna-Lena
    Khoeiklang, Martin
    Quinn, Carol P. Moreno
    Kretz, Martin
    Bauer, Michael
    Li, Lingyun
    Wilhelm, Maria
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 386 - 386
  • [25] Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions
    Muenster, Uwe
    Grieshop, Birgit
    Ickenroth, Karsten
    Gnoth, Mark Jean
    PHARMACEUTICAL RESEARCH, 2008, 25 (10) : 2320 - 2326
  • [26] Quantitative Prediction of Renal Transporter-Mediated Clinical Drug-Drug Interactions
    Feng, Bo
    Hurst, Susan
    Lu, Yasong
    Varma, Manthena V.
    Rotter, Charles J.
    El-Kattan, Ayman
    Lockwood, Peter
    Corrigan, Brian
    MOLECULAR PHARMACEUTICS, 2013, 10 (11) : 4207 - 4215
  • [27] Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions
    Feng, Bo
    Varma, Manthena V.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 : S110 - S121
  • [28] Evaluation of the potential drug interactions mediated through P-gp, OCT2, and MATE1/2K with filgotinib in healthy subjects
    Hsueh, Chia-Hsiang
    Anderson, Kacey
    Shen, Gong
    Yun, Chohee
    Qin, Ann
    Othman, Ahmed A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (02): : 361 - 370
  • [29] A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
    Lee, Jonghwa
    Beers, Jessica L.
    Geffert, Raeanne M.
    Jackson, Klarissa D.
    BIOMOLECULES, 2024, 14 (01)
  • [30] Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions
    McGinnity, Dermot F.
    Waters, Nigel J.
    Tucker, James
    Riley, Robert J.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 1126 - 1134
12345